In the healthcare industry, promoting wellness is a team effort that pays significant attention to infection control. The image of a bustling hospital ward, with dedicated healthcare personnel diligently checking on patients, casts a striking illustration of the centrality of infection control in patient wellbeing. One particular culprit, the toxin-producing Clostridioides difficile, has been flagged as a high-risk concern for infection control within hospital environments.
A bacteria traditionally resident in human intestines, C. difficile poses a threat of rapid spread, particularly in situations involving close contact between patients and healthcare workers. An investigation involving comprehensive culture tests alongside single nucleotide polymorphism (SNP) analysis through draft whole-genome sequencing (WGS) has revealed previously unnoticed transmissions within hospital wards. These unnoticed transmissions were predominantly traced back to cases involving rampant room changes and multiple patient admissions.
By utilizing WGS-measured modes of analysis to closely monitor transmission rates of C. difficile, healthcare professionals can devise effective strategies for managing infection control. From the study, 38 strains were classified into 11 sequence types (STs), with ST81, ST183, and ST17 ranking as the most prevalent. Specifically, clusters of strains linked to Suspected Nosocomial Transmission (SNT) were unveiled through SNP analysis. Draft WGS, in its part, identified five clusters collectively encompassing 16 out of 38 strains.
In a bid to unravel C. difficile’s patterns of transmission within a given healthcare facility, researchers dig into its genetic relationships through the employment of draft WGS and an analysis of SNPs found in the core genome. Supplementing this effort is data on patients’ hospital wards and histories of room changes.
Despite its insightful findings, the study is not devoid of limitations. Primarily it being single-center and retrospective in nature, the scope of its focus limited to nosocomial transmission of C. difficile. Among other factors not considered are data on C. difficile infection (CDI) or antimicrobial use, screening records for asymptomatic patients sharing a room with CDI patients, and an assessment of silent transmission’s impact on infection control and healthcare expenses. Further, only the first strain isolated from each patient underwent analysis, potentially overlooking instances of patients harbouring multiple genetically distinct strains of C. difficile.
Despite these limitations, the study, much like the CDC’s use of WGS, plays into the enhancement of detection of minor outbreaks and puts a spotlight on the problem of underreporting. Overall, both studies solidly advocate for the fundamental part genomic methods play in bolstering infection control and handling infections. They also underscore the pressing need for innovation in executing public health practices.